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Abstract
Identification of patients colonized with methicillin-resistant Staphylococcus aureus (MRSA) and subsequent isolation and decolonization is
pivotal to the control of cross infection in hospitals. The aim of this study was to establish if early identification of colonized patients
using rapid methods alone reduces transmission. A prospective, cluster, two-period cross-over design was used. Seven surgical wards at
a large hospital were allocated to two groups, and for the first 8 months four wards used rapid MRSA screening and three wards used
a standard culture method. The groups were reversed for the second 8 months. Regardless of the method of detection, all patients
were screened for nasal carriage on admission and then every 4 days. MRSA control measures remained constant. Results were analy-
sed using a log linear Poisson regression model. A total of 12 682/13 952 patient ward episodes (PWE) were included in the study.
Admission screening identified 453 (3.6%) MRSA-positive patient ward episodes, with a further 268 (2.2%) acquiring MRSA. After adjust-
ing for other variables, rapid screening was shown to statistically reduce MRSA acquisition, with patients being 1.49 times (p 0.007)
more likely to acquire MRSA in wards where they were screened using the culture method. Screening of surgical patients using rapid
testing resulted in a statistically significant reduction in MRSA acquisition. This result was achieved in a routine surgical service with high
bed occupancy and low availability of isolation rooms, making it applicable to the majority of health-care systems worldwide.
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is an impor-
tant hospital-acquired infection, the prevalence of which has
increased, despite the introduction of multifaceted control
measures [1,2]. Successful control measures have mainly
relied upon the identification and isolation of colonized and
infected patients to prevent them acting as a reservoir of
infection and onward transmission [3–6]. The important
unanswered question, addressed by this study, is whether a
more rapid diagnosis of colonization or infection confers addi-
tional benefits over traditional culture-based methods [7].
Recently developed molecular methods, using PCR have
the potential to confirm or refute colonization and infection
of individual patients within 2 h. One such commercially
available real-time PCR test links mecA, the gene responsible
for methicillin resistance, to a S. aureus genomic background,
thereby avoiding false positives [8]. Several studies have eval-
uated this test and shown it to have both high sensitivity and
negative predictive value [9–12].
We have designed and executed a prospective controlled
cross-over study within the surgical wards of a single large hos-
pital to test the hypothesis that early identification of MRSA
colonized and infected patients reduces onward transmission
of MRSA compared with traditional culture-based methods.
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases
ORIGINAL ARTICLE 10.1111/j.1469-0691.2009.02899.x
Materials and Methods
Study setting and design
The study was based in a large teaching hospital of 1200
beds and carried out in seven surgical wards (number of
wards): general surgery (2), thoracic (1), ear, nose and throat
(ENT) (1), trauma and orthopaedic (2) and urology (1). Each
ward had between 20 and 34 beds, arranged in bays of six
beds and two to five single isolation rooms.
A prospective, cluster two-period cross-over design was
used, with the only difference between the two periods
being the method of MRSA detection [13]. The study com-
pared the use of rapid MRSA testing with the BD Gene-
Ohm molecular test (BD Diagnostics—GeneOhm, San
Diego, CA, USA) with a standard direct inoculation culture
method using chromogenic (MRSA ID) media (Biomerieux,
Marcy, l’Etoile, France). Wards were assigned to one of two
groups (A to D and E to G), with wards of a similar specialty
being placed in opposite groups. An initial study over a
2-month pilot period, after group assignment and intro-
duction of test methods, was conducted according to the
study protocol. This was followed by two 8-month cross-
over periods, with 1-month follow-up of study patients at
the end of the final period.
A screening protocol was implemented, requiring all adult
patients admitted for >24 h to have a nasal sample taken on
admission. In order to identify transmission events and acqui-
sition while on the ward, all patients who were negative on
admission were re-screened every 4 days until discharge.
Patients known to be positive from previous admission were
still screened on admission.
Laboratory procedures and reporting
On receipt in the laboratory all swabs, including those from
the wards where the samples were being tested using the
rapid test, were inoculated directly onto chromogenic cul-
ture media. Subsequently the swabs requiring the rapid test
were processed according to the manufacturer’s instructions.
Rapid results were reported immediately on completion of
the test without awaiting a culture result. Culture plates
were read after 18-h incubation and MRSA isolates con-
firmed the following day using standard methods [14]. Mup-
irocin sensitivity was carried out on all isolates according to
British Society Antimicrobial Chemotherapy methods.
Where there were discrepant results between rapid and cul-
ture tests, samples were placed in broth enrichment, incu-
bated overnight and then sub-cultured onto chromogenic
media. Results from all tests were entered on the hospital
reporting system and all positive MRSA results, rapid and
culture, were telephoned. A 7 day per week service was
provided.
Infection control procedures
All wards were provided with the same infection control
guidelines, which remained unchanged for the duration of
the study. Only upon a positive test result were patients
placed under control measures. These included placing the
patients in an isolation room, if available, and placement of
an isolation precaution sign detailing the infection control
measures, including hand hygiene and the wearing of an
apron, that should be taken either on entry to the room or
above the bed space. Gloves were only required when
handling blood, body fluids, secretions, excretions and con-
taminated materials. All patients were commenced on decol-
onization treatment [nasal mupirocin or naseptin for strains
with high level mupirocin resistance and triclosan body wash
(Aquasept) administered three times a day for 5 days].
Data collection
Dedicated staff collected a comprehensive set of data for all
patients admitted to the study wards. This included demo-
graphic information, risk factors, source of admission, antibi-
otic usage, length of stay, bed movements and type of
surgery. For all patients who were colonized or infected with
MRSA, the times of implementation of infection control mea-
sures and decolonization treatment were also recorded.
Turnaround times for MRSA screening results, from taking a
sample to reporting, were recorded for all samples.
Outcome measures
The primary outcome of the study was the acquisition rate
of MRSA colonization. As a result of differences in sensitivity
between the rapid and culture tests, acquisition rates were
calculated using only culture results which were obtained
consistently in all arms of the study. A patient was deemed
to be colonized with MRSA on admission to a ward if MRSA
was isolated within 48 h of admission. If a patient did not
have an admission sample, but a negative sample was taken
within 4 days of the ward admission, the patient was
regarded as not being colonized with MRSA on admission.
Patients were excluded from the analysis if they had no sam-
ples taken or if they had a positive 4-day sample, but no
admission sample (Fig. 1).
In order to account for colonization pressure, acquisition
rates were calculated as the ratio of the number of patients
acquiring MRSA on the ward to the number of patients who
were MRSA positive on admission. Analysis was carried out
at the ward level and, to take account of the fact that during
the study some patients moved between study wards,
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analysis was carried out using patient ward episodes (PWE),
i.e. each separate ward admission for the same patient was
counted. A patient was regarded as being colonized with
MRSA from the point at which it was first detected and then
for the duration of their admission.
Statistical analysis
A log-linear Poisson regression model was used to analyse
counts of new MRSA acquisitions on each ward during each
study period. The analysis was carried out in SPSS v.15 (SPSS
Inc., Chicago, IL, USA). The log of the number of MRSA col-
onizations on admission to each ward in each period was
included in the model as an offset variable so that model
parameters correspond to estimates of the MRSA acquisition
rate. A stepwise model fitting approach was adopted to
investigate the effects of the potential confounding factors,
including age, length of stay in the ward, proportion of
patients undergoing elective or emergency surgery, source of
admission, critical care admission and antibiotic usage,
enabling adjustment of the effect of test method (rapid vs.
culture) on the number of new MRSA colonizations. Overall
model improvement was assessed after adding each of the
potential confounders and the final model retained those
variables that were significant at the 5% level. For compari-
son, MRSA incidence rates per 100 bed days were calculated
for each study period. The rates were compared using a log-
linear Poisson regression model, adjusted for ward, period
and test method.
Results
During the study period (January 2005 to April 2007), a total
of 10 934 patients were admitted to the study wards
amounting to 13 952 PWE. A total of 1270 (9.1%) PWE
were excluded from the analysis; 32 (0.2%) had no admission
sample taken and 1238 (8.8%) had no samples taken. These
patients had a shorter length of stay (mean 3 days) than
patients included in the study. Characteristics of the patient
groups across the study periods are shown in Table 1. Over-
all, there were 453 (3.6%) PWE in which the patient was
MRSA culture positive on admission to the ward; 187 (2.8%)
in the culture arm and 266 (4.4%) in the rapid arm. Based on
culture results only, MRSA was acquired during 157 (2.4%)
PWE in the culture arm and 111 (1.9%) PWE in the
rapid arm.
13,952 eligible PWE
Culture arm
7493 eligible PWE
Rapid arm
6459 eligible PWE
Screened:
n = 6671 (89.0%)
Not screened:
n = 822
Screened:
n = 6011 (93.1%)
Not screened:
n = 448
A
na
ly
si
s 
ex
cl
us
io
ns
MRSA negative:
n = 6327
MRSA negative:
n = 5634
Positive on
admission:
n = 187
Acquisitions:
n = 157
Positive on
admission:
n = 266
Acquisitions:
n = 111
Cu
ltu
re
 re
su
lts
MRSA positive:
n = 344 (5.2%)
MRSA positive:
n = 377 (6.3%)
FIG. 1. Flow of study patients. MRSA,
methicillin-resistant Staphylococcus aur-
eus; PWE, patient ward episodes.
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A total of 808 PWE were positive with the rapid test, of
which 377 were positive using direct culture and a further
140 using broth enrichment.
The final fitted model for MRSA acquisition rate included
terms for ward, period (pre or post cross-over), log of the
mean length of stay on a ward, log of proportion of patients
undergoing emergency surgery and test method (rapid vs. cul-
ture). Logs were taken of the two continuous variables (mean
length of stay on ward and proportion of patients undergoing
emergency surgery) to reflect the log link in the Poisson
model. There was a significant ward effect in the model and a
significant period effect after adjusting for all other factors
(Table 2). Both length of stay on the ward and the proportion
of emergency surgical procedures carried out on a ward sig-
nificantly increased the likelihood of MRSA acquisition. After
adjusting for all other variables in the model, the test method
(rapid vs. culture) was shown to have a significant effect on
the numbers of patients acquiring MRSA during a ward stay,
with an estimated rate ratio of 1.49 (95% confidence interval
1.115–2.003; p 0.007). This shows that patients on wards
during the culture period were 1.49 times more likely to
acquire MRSA than during the rapid period. The incidence
rates per 100 bed days for the rapid and culture periods
were, respectively, 0.286 and 0.410 (p 0.002).
Six out of the seven wards saw a decrease in the number
of MRSA acquisitions during the periods of the study when
the rapid test was utilized (Table 3). Ward B, an ENT ward
which has a rapid turnover of patients and a low rate of
acquisition, saw an increase in the acquisition rate (Table 4
and S3). During the study, there was a minor change to the
admission policy on ward B which resulted in an increase in
short-stay patients (Table S1).
Turnaround times and compliance with isolation
procedures
The time from sample taking to result reporting was calcu-
lated for all samples. The mean time for reporting positive
results for the rapid test was 0.9 days vs. 3.3 days for the
culture test (Table 4). The mean time from result reporting
to decolonization treatment was comparable in the two
study periods (Table 4). The percentage of MRSA colonized
patients nursed in isolation rooms was low in both study
arms (Table 4).
Discussion
The present study has shown, within the rigorous constraints
of a controlled trial, that rapid MRSA screening significantly
reduces MRSA transmission within surgical wards of a
large hospital when compared with standard culture-based
TABLE 1. Patient characteristics
from the two study periods
Study period
p-valueCulture Rapid
Total number of PWE 7493 6459 <0.001
Number of PWE excluded from analysis 822 (11.0%) 448 (6.9%) <0.001
Number of admission samples 6671 6011 <0.001
Number of post admission samples 8516 9292 <0.001
Age (mean, years) 57.1 59.1 0.157
Male 3663 (54.9%) 3425 (57.0%) 0.005
Patients admitted from nursing home 68 (1.0%) 76 (1.3%) 0.505
Patients admitted from other hospital ward 1053 (15.8%) 1016 (16.9%) 0.416
Mean length of stay on ward (days) 6.5 7.2 0.374
Mean length of hospital stay (days) 9.7 10.6 0.365
Patient undergoing surgical procedure 2807 (42.1%) 2989 (49.7%) 0.017
Emergency surgery 1429 (21.4%) 1411 (23.5%) 0.736
Antibiotic prophylaxis 1700 (25.5%) 1779 (29.6%) 0.180
Antibiotics (excluding prophylaxis) 1258 (18.9%) 1223 (20.3%) 0.482
Ward episode followed by admission to critical care 551 (8.3%) 558 (9.3%) 0.455
Ward episode after discharge from critical care 665 (10.0%) 638 (10.6%) 0.834
PWE, patient ward episodes.
Note: all of the above data, apart from total number of patients, relate to patient ward episodes.
Log-linear Poisson models, adjusted for ward, were used to compare counts in the two arms. Two-sample t-tests
were used to compare the within-ward differences in lengths of stay and mean ages, allowing for ward and period
effects. These were carried out in SPSS V.15. A random effects logistic regression model was used to compare the
proportion of PWE excluded from the two arms using SAS v.9.1.
TABLE 2. Parameter estimates and rate ratios for the fitted
log-linear model
Parameter
Estimated
rate ratio 95% C.I. p value
Period (Pre or post cross-over) 0.356 (0.230, 0.701) < 0.001
log(mean length of stay on ward) 89.971 (13.782, 587.362) < 0.001
log(emergency surgery)a 27.694 (4.260, 180.058) 0.001
Test method: culture
(rapid test is reference level)
1.494 (1.115, 2.003) 0.007
alog(emergency surgery) = log(proportion of patients undertaking emergency
surgery on each ward).
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techniques. This finding has important implications for the
control and management of MRSA in institutions where
MRSA is endemic and there is limited availability of isolation
rooms. The shortened turnaround time to MRSA result
ensures that the risk of transmission occurring from a
patient not known to be colonized is reduced [6].
In most UK hospitals there are small numbers of single
rooms available for patient isolation. This explains the very
low compliance with isolation in both arms of the study
(approximately 17%) meaning that the dominant inter-
vention was early patient identification; resulting in the
implementation of infection control precautions and decol-
onization treatment. Early notification of MRSA in the
rapid arm resulted in a greater percentage of patients
receiving decolonization treatment, with a higher percent-
age of the culture arm being discharged before the result
was available and therefore receiving no decolonization
treatment.
Since the introduction of rapid molecular tests, other
studies have been published investigating the impact of these
tests on MRSA transmission and infection rates [15–22]. The
majority of these have a retrospective, time intervention
study design which does not control for confounding vari-
ables. Our study adopted a prospective cross-over design,
enabling the elimination of sampling biases and ensuring, as
far as possible, that there were no changes to the ward envi-
ronment or practices during the study. Although the wards
were not randomized, they were matched as far as possible
to ensure that seasonal bias was not introduced. No wash
out period was used as no operational changes were
required, but this did result in a nominal delay (<48 h) for
five positive patients.
Two other studies have used a cross-over design; the first
assessed the impact of screening patients rapidly on admis-
sion vs. no screening on infection rates [20]. The second
assessed the impact of rapid screening vs. conventional cul-
ture and had a high compliance with admission screening
(93.4%), but a larger number of patients were lost to follow-
up (17.8%) so that transmission rates may have been under-
estimated [21]. In addition, pre-emptive isolation (i.e. before
TABLE 4. Compliance with infec-
tioncontrolguidelines
Study period
p-valueCulture Rapid
MRSA colonization on admission 187 266 <0.001
MRSA acquisition 157 111 0.005
Total colonized with MRSA 344 377 0.219
Mean length of time on the ward to MRSA acquisition (days) 13.0 12.9 0.894
Percentage isolated in isolation rooms 16.3% (56/344) 17.5% (66/377) <0.001
Percentage prescribed decolonization treatment 41.3% (142/344) 71.1% (268/377) <0.001
Mean length of time to MRSA positive result reporting (days)a 3.3 0.9 <0.001
Mean length of time from reporting to prescribing
decolonization treatment (days)
0.7 0.7 1.000
MRSA, methicillin-resistant Staphylococcus aureus.
Note: The rapid arm calculations are made using data only from those patients who were positive by both the rapid
test and culture.
aDenominator figures represent ward episodes in which MRSA colonization was first detected.
Log-linear Poisson models, adjusted for ward, were used to compare counts in the two arms. Two-sample t-tests
were used to compare the within-ward differences in lengths of time, allowing for ward and period effects.
TABLE 3. Methicillin-resistant Staphylococcus aureus (MRSA) transmission rates for each study period (culture vs. rapid) based
on culture-positive samples
Ward Specialty
Culture Rapid
Number
of patient
ward
episodes
MRSA
positive on
admission
to ward
MRSA
acquired
during ward
admission
MRSA
acquisition
ratio
Number
of patient
ward
episodes
MRSA
positive on
admission
to ward
MRSA
acquired
during ward
admission
MRSA
acquisition
ratio
Aa Thoracic 997 18 36 2.0 1088 58 18 0.31
Ba Ear, nose, throat 1933 27 4 0.15 894 22 6 0.27
Ca General surgery 1050 32 20 0.63 1070 60 34 0.57
Da Trauma and orthopaedics 543 16 11 0.69 479 17 8 0.47
E Urology 638 29 36 1.24 788 43 15 0.35
F General surgery 1065 41 38 0.93 1171 49 23 0.47
G Trauma and orthopaedics 445 24 12 0.50 521 17 7 0.41
Total All 6671 187 157 0.84 6011 266 111 0.42
aWards which were in the molecular arm of the study first.
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microbiological screening) of patients at high risk of MRSA
colonization was used [21]. We believe these two factors
resulted in a much lower detected transmission rate, 0.36 as
opposed to 0.84 in our study.
Elucidation of the impact of rapid screening in previous
studies has been hampered by the introduction of multiple
interventions, for example the introduction of rapid screen-
ing and pre-emptive isolation [19].
Re-screening patients every 4 days may well have contrib-
uted to the effectiveness of rapid testing, with new acquisitions
being identified more promptly. All of the other published
studies reporting the effects of rapid testing have focused on
admission screening and used the availability of clinical or dis-
charge samples as evidence of transmission. There is evidence
that using either clinical samples or discharge screening to
determine transmission events will result in an under reporting
[23–25]. Harbarth and colleagues used only passive surveil-
lance and, as they acknowledge, this may have resulted in some
MRSA infections being missed, which they felt the cross-over
design would account for [20]. However, only patients in the
test group were screened for MRSA, possibly resulting in an
increased awareness and reporting of infection in this group.
As has been reported in other studies, some samples were
positive using the rapid test although we were unable to grow
MRSA using direct culture [16]. This is partly as a result of
the increased sensitivity of molecular tests, with direct
inoculation being known to be less sensitive than broth
enrichment. Interestingly, unlike Conterno and colleagues,
who deemed all samples that were positive using the rapid
test and negative using culture to be false positives and
ceased to isolate and decolonize the patient, the present
study continued to treat the patient as positive [16], which
may account for the differing results from the two studies.
This study provided a challenging test of the value of rapid
vs. slower culture based methods for MRSA screening
because of the limited availability of isolation rooms [26].
We conclude that the introduction of MRSA screening using
rapid tests and the protocol we have described can signifi-
cantly reduce MRSA transmission on wards that have a lim-
ited number of isolation rooms.
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